OverviewChartNewsTraderScreen

Anthera Pharmaceuticals, Inc./  US03674U3005  /

Nasdaq Other OTC
2024-08-21  7:47:54 PM Chg. - Volume Bid- Ask- High Low
0.0000USD - 1,081
Turnover: .0006		 -Bid Size: - -Ask Size: - 0.0000 0.0000
GlobeNewswire 2021-11-23 Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VIS...
GlobeNewswire 2021-08-02 Oyster Point Pharma Announces New Chairperson Appointment to Board of Directors
GlobeNewswire 2020-09-10 Opthea Appoints US-Based Non-Executive Director
GlobeNewswire 2020-07-08 Atossa Therapeutics Advances Product Development Programs with Multiple Key Hires in Clinical, Regul...
GlobeNewswire 2019-05-16 Geron Continues to Build Senior Leadership of Its Development Team
GlobeNewswire 2019-01-22 Apollomics, Inc. Strengthens Leadership with Key Hires
GlobeNewswire 2018-08-31 Report: Developing Opportunities within Anthera Pharmaceuticals, NRG Energy, Antares Pharma, El Poll...
GlobeNewswire 2018-08-22 Global Oral Proteins and Peptides Market 2018-2030 - Current Market Landscape of Orally Administrabl...
GlobeNewswire 2018-06-27 Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading...
GlobeNewswire 2018-05-30 AzurRx Announces Appointment of Dr. James Pennington as Chief Medical Officer
GlobeNewswire 2018-05-16 Oral Proteins and Peptides Market, 2030
GlobeNewswire 2018-05-04 New Research: Key Drivers of Growth for Global Medical REIT, DXP Enterprises, SJW, FTI Consulting, A...
GlobeNewswire 2018-03-19 Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight M...
GlobeNewswire 2018-03-13 World Novel Drugs and Smart Devices for Respiratory Disorders Market, 2030
GlobeNewswire 2018-03-12 Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura
GlobeNewswire 2018-03-07 Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference
GlobeNewswire 2018-03-06 Anthera Pharmaceuticals Deemed Compliant with Nasdaq Listing Criteria
GlobeNewswire 2018-03-05 Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Fin...
GlobeNewswire 2018-02-08 Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference and SunTrust Robinson Hu...
GlobeNewswire 2018-02-05 Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura
GlobeNewswire 2018-01-25 Anthera Receives Positive Nasdaq Listing Determination
GlobeNewswire 2018-01-22 Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinica...
GlobeNewswire 2018-01-17 Report: Exploring Fundamental Drivers Behind Anthera Pharmaceuticals, Alarm, Aptevo Therapeutics, Sh...
GlobeNewswire 2018-01-09 Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering
GlobeNewswire 2018-01-08 Anthera Pharmaceuticals Announces Results of Special Meeting of Stockholders